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Mycoplasma pneumoniae, which causes mycoplasmal pneumonia in human, mainly
causes pneumonia in children, although it occasionally causes disease in infants and
geriatrics. Some pathogenic factors produced by M. pneumoniae, such as hydrogen
peroxide and Community-Acquired Respiratory Distress Syndrome (CARDS) toxin have
been well studied. However, these factors alone cannot explain this predilection. The
low incidence rate of mycoplasmal pneumonia in infants and geriatrics implies that
the strong inflammatory responses induced by M. pneumoniae coordinate with the
pathogenic factors to induce pneumonia. However, M. pneumoniae lacks a cell wall
and does not possess an inflammation-inducing endotoxin, such as lipopolysaccharide
(LPS). In M. pneumoniae, lipoproteins were identified as an inflammation-inducing
factor. Lipoproteins induce inflammatory responses through Toll-like receptors (TLR)
2. Because Mycoplasma species lack a cell wall and lipoproteins anchored in the
membrane are exposed, lipoproteins and TLR2 have been thought to be important
for the pathogenesis of M. pneumoniae. However, recent reports suggest that M.
pneumoniae also induces inflammatory responses also in a TLR2-independent manner.
TLR4 and autophagy are involved in this TLR2-independent inflammation. In addition,
the CARDS toxin or M. pneumoniae cytadherence induces inflammatory responses
through an intracellular receptor protein complex called the inflammasome. In this
review, the inflammation-inducing factors of M. pneumoniae are summarized.
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INTRODUCTION
Mycoplasma pneumoniae causes primary atypical pneumonia, tracheobronchitis, pharyngitis, and
asthma in humans (Gil et al., 1993; Kraft et al., 1998; Waites and Talkington, 2004). The age
distribution of patients with pneumonia caused by M. pneumoniae is characteristic. The incidence
is highest among school-aged children and young adults and lower in infants and geriatrics (Denny
et al., 1971; Foy et al., 1979). Some pathogenic factors of M. pneumoniae, such as hydrogen
peroxide, Community-Acquired Respiratory Distress Syndrome (CARDS) toxin, and nuclease,
have been reported to be associated with the development of pneumonia (Somerson et al.,
1965; Cohen and Somerson, 1967; Kannan and Baseman, 2006; Hames et al., 2009; Somarajan
et al., 2010). However, these pathogenic factors are insufficient to explain the age distribution of
patients with pneumonia caused by M. pneumoniae. Generally, the immune system in infants and
geriatrics is immature compared with that in young adults. The symptoms of pneumonia caused
by M. pneumoniae are correlated with the induction of pro-inflammatory cytokines (Tryon and
Baseman, 1992; Salvatore et al., 2007). These findings suggest that the excessive immune responses
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induced by M. pneumoniae play an important role in the
development of pneumonia. In this review, the molecular
mechanisms of inflammation induced by M. pneumoniae are
summarized (Table 1).
LIPOPROTEINS AND TOLL-LIKE
RECEPTORS (TLRs)
Lipoproteins of Mycoplasma Species
It has been reported that some Mycoplasma species induce
pro-inflammatory cytokines and stimulate various immune
cells (Atkin et al., 1986; Kirchner et al., 1986; Teh et al., 1988).
Because Mycoplasma species are devoid of a cell wall and
lack immune cell stimulator such as lipopolysaccharide (LPS)
or peptidoglycan (Mizel et al., 1978; Staber et al., 1978), the
factors responsible for the induction of inflammatory responses
have been unclear for a long time. The first report on the
inflammation-inducing factor of Mycoplasma species was
published by Quentmeier et al. (1990). They reported that
a high-molecular-weight (HMW) protein of M. fermentans
known as MDHM possesses interleukin (IL)-6-inducing
activity in macrophages. Because the activity of MDHM was
resistant to proteinase K, the active component of MDHM
was thought to be a low-molecular-weight compound. In 1996,
Muhlradt et al. identified the active component of MDHM
as S-(2,3-dihydroxypropyl) cysteine (Muhlradt et al., 1996).
This component was similar to the N-terminal structure
of an Escherichia coli-derived lipoprotein identified in 1969
by Braun et al. Braun (1975). Muhlradt et al. (1997) also
purified the inflammation-inducing factor from M. fermentans
culture and demonstrated that the active component
is the diacylated lipopeptide, S-(2,3-bisacyloxypropyl)-
CGNNDESNISFKEK. They named it macrophage-activating
TABLE 1 | Summary of the inflammation-inducing factors of Mycoplasma
pneumoniae.
Gene ID Original function Function in inflammation
MPN602 F0F1 ATP synthase subunit b Diacylated lipoprotein
MPN052
Hypothetical Triacylated lipoprotein
MPN162
MPN415
MPN611
MPN141 Cytadherence, P1 adhesin Pro-inflammatory cytokine
induction
MPN142 Cytadherence, P40, P90
Activation of inflammasome
MPN453 Cytadherence, P30
MPN447 Cytadherence, HMW1
MPN372 ADP-ribosylating toxin,
CARDS toxin
MPN333 ABC transporter Autophagy/TLR4 dependent
MPN597 F0F1 ATP synthase subunit ε inflammation
lipopeptide-2 (MALP-2). After these reports, inflammation-
inducing lipoproteins were purified and identified in various
Mycoplasma species (Jan et al., 1996a; Muhlradt et al., 1997, 1998;
Shibata et al., 2000), including M. pneumoniae (Shimizu et al.,
2005).
Structure of Lipoprotein and TLR
Lipoproteins were discovered in 1969 by Braun et al. (Braun,
1975). Lipoproteins are hydrophilic membrane proteins
characterized by a conserved N-terminal lipid-modified cysteine
residue. Lipoproteins contain S-glyceryl cysteine modified
with three fatty acids (N-acyl-S-diacylglyceryl cysteine) at
their N-terminal. This triacylated structure is also called
Braun’s lipoprotein. Braun’s Lipoproteins are synthesized
by the following three steps (Figure 1): (1) Transfer of the
diacylglyceryl moiety from a membrane phospholipid to a
cysteine residue of a protein through the recognition of the
lipobox (L-[A/S/T]-[G/A]-C) by prolipoprotein diacylglyceryl
transferase (Lgt); (2) Digestion of the signal sequence at the
amino-terminal side of the cysteine by prolipoprotein signal
peptidase (Lsp); and (3) Linkage of an acyl chain to the
amino group of the amino-terminal cysteine (N-acylation)
by prolipoprotein N-acyl-transferase (Lnt). Because genes
orthologous to Lnt gene are not found in some bacterial species
(Firmicutes and and Tenericutes), including Mycoplasma
species, lipoproteins from these bacterial species have been
assumed to be of the diacylated form (Nakayama et al.,
2012).
Toll-like receptors are a type of pattern-recognition receptors
that play critical roles in early innate recognition and host
inflammatory responses against invading microbes (Kopp and
Medzhitov, 1999; Akira and Takeda, 2004). Among the 11
reported TLR family members, TLR2 plays a central role in the
recognition of lipoproteins. TLR2 recognizes the S-diacylglyceryl
cysteine portions of both diacylated and triacylated lipoproteins
(Botos et al., 2011). TLR1 coordinate with TLR2 to recognize
triacylated lipoproteins through the recognition of the third
acyl chain amide-linked to the cysteine using a hydrophobic
pocket within TLR1 (Jin et al., 2007). However, TLR2 alone is
not able to recognize diacylated lipoproteins. TLR6 assists in
the recognition of diacylated lipoproteins by associating with
the amino acid portion of diacylated lipoproteins (Kang et al.,
2009). Although there are some exceptions (Buwitt-Beckmann
et al., 2005; Kurokawa et al., 2009), diacylated and triacylated
lipoproteins are generally recognaized by TLR2/6 and TLR2/1
heterodimers, respectively.
The presence of triacylated lipoproteins in Mycoplasma
species has been controversial. The lipoproteins from
M. fermentans, M. hyorhinis, M. salivarium, and M. gallisepticum
have been shown to be diacylated lipoproteins and not N-acylated
(Jan et al., 1996a; Muhlradt et al., 1997, 1998; Shibata et al., 2000).
The Lnt gene, which encodes the enzyme responsible for
N-acylation has not been found in any mycoplasma genomes
(Fraser et al., 1995; Himmelreich et al., 1996; Sasaki et al., 2002).
However, a study on the ratio of N-amide and O-ester bonds
in M. gallisepticum and M. mycoides suggested the presence
of triacylated lipoproteins (Jan et al., 1996b). Furthermore, the
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FIGURE 1 | Biosynthesis of bacterial lipoproteins. (1) Lgt transfers a diacylglyceryl moiety from a phospholipid to the sulfhydryl group of the cysteine located
after the lipobox sequence. (2) Lsp cleaves the signal peptide at the N-terminus of the cysteine. (3) Lnt transfers an acyl chain derived from phospholipid to the
amino group of the cysteine.
resistance to Edoman degradation of proteins from M. mycoides
also indicated the presence of N-acylation (Chambaud et al.,
1999). These data imply the presence of triacylated lipoproteins
in Mycoplasma species.
Lipoproteins of M. pneumoniae
Lipoproteins of M. pneumonie are summarized in Table 2.
In M. pneumoniae, Shimizu et al. (2005) reported that the
subunit b of the F0F1 ATP synthase (MPN602) is a diacylated
lipoprotein that induces inflammatory responses through TLR2.
Into et al. (2007) also reported that M. pneumoniae has 48
lipoproteins and that the common N-terminal structure of these
lipoproteins induces inflammatory responses. Interestingly,
Some of these lipoproteins (MPN162, MPN611) were recognized
by TLR1 and TLR2, suggesting that M. pneumoniae contains
triacylted lipoproteins (Shimizu et al., 2007). Kurokawa et al.
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TABLE 2 | Summary of lipoproteins of M. pneumoniae.
Gene ID Gene
symbol
Original function Usage
of TLR
Number of
acyl chain
MPN011 Hypothetical
MPN052 Hypothetical 3a
MPN054 Hypothetical
MPN058 Hypothetical
MPN083 Hypothetical
MPN097 Pseudo
MPN133 Hypothetical
MPN152 Hypothetical
MPN162 Hypothetical 1, 2 3b
MPN199 Hypothetical
MPN200 Hypothetical
MPN271 Hypothetical
MPN281 Pseudo
MPN284 Hypothetical
MPN288 Hypothetical
MPN363 Hypothetical
MPN369 Hypothetical
MPN408 Hypothetical
MPN411 Hypothetical
MPN415 High affinity transport system
protein P37
3a
MPN436 Hypothetical
MPN439 Pseudo
MPN442 Hypothetical
MPN456 Hypothetical
MPN459 Hypothetical
MPN467 Hypothetical
MPN489 Hypothetical
MPN506 Hypothetical
MPN523 Hypothetical
MPN582 Hypothetical
MPN585 Hypothetical
MPN587 Hypothetical
MPN588 Hypothetical
MPN590 Hypothetical
MPN592 Hypothetical
MPN602 atpF F0F1 ATP synthase subunit b 2, 6 2b
MPN611 Phosphate ABC transporter
substrate-binding protein
1, 2 3b
MPN639 Hypothetical
MPN640 Hypothetical
MPN641 Hypothetical
MPN642 Hypothetical
MPN643 Hypothetical
MPN644 Hypothetical
MPN645 Hypothetical
MPN646 Hypothetical
MPN647 Hypothetical
MPN650 Hypothetical
MPN654 Hypothetical
aDetermined by lipase-based mass spectrometry analysis.
bEstimated from TLR usage.
(2012) analyzed the detailed structure of M. pneumoniae
lipoproteins using lipoprotein lipase-based mass spectrometry
analysis, and demonstrated that some of M. pneumoniae
lipoproteins (MPN052, MPN415) are triacylated. In this study,
triacylated lipoproteins were also found in M. genitalium.
These findings led to the conclusion that Mycoplasma species
possess triacylated lipoproteins and indicated that a new
enzyme with Lnt activity exists in Mycoplasma species.
Although the modification of other 43 lipoproteins of M.
penoumoniae is still unclear, the lipoproteins of M. pneumoniae
seem mixture of diacylated and triacylated lipoproteins.
Induction of inflammatory responses through both TLR2/6
and TLR2/1 by diacylated and triacylated lipoproteins
may affect the strong inflammation in M. pneumoniae
infection.
TLR2-INDEPENDENT INFLAMMATION
M. pneumoniae and Autophagy
Because Mycoplasma species lack cell walls, they do not
contain immunostimulants such as LPS, peptidoglycan, or
lipoteichoic acid. Therefore, lipoproteins seem to be key
factors in M. pneumoniae-induced inflammatory responses
and to facilitate the development of pneumonia in humans.
However, the existence of lipoproteins in non-pathogenic
Mycoplasma species suggests the presence of an alternative
mechanism by which M. pneumoniae induce inflammatory
responses.
Autophagy is a cellular response that involves the
sequestration of regions within the cytosol with double
membrane compartments. Autophagy has been shown to play
important roles in the cellular response to starvation, cell death,
removal of damaged organelles, and neurodegenerative diseases
(Levine, 2005). It has recently been recognized that autophagy is
involved in both innate and adaptive immunity against various
microorganisms (Schmid and Munz, 2007; Deretic et al., 2013;
Ma et al., 2013).
Recently, Shimizu et al. demonstrated that M. pneumoniae
induces strong inflammatory responses, even in macrophages
derived from TLR2 knockout (KO) mice (Shimizu et al.,
2014). M. pneumoniae internalized into macrophages through
phagocytosis were co-localized with the autophagosome,
and autophagy inhibitors decreased the induction of pro-
inflammatory cytokines, suggesting the autophagy-mediated
induction of inflammatory responses. Because this TLR2-
independent induction was inhibited in macrophages derived
from TLR2/4 double KO mouse, TLR4 is also involved. In this
study, they also reported that the ABC-transporter (MPN333),
and F0F1 ATP synthase subunit ε (MPN597) of M. pneumoniae
are essential for the activation of the autophagy/TLR4-mediated
pathway.
M. pneumoniae and the Inflammasome
Inflammasomes are intracellular receptors (Martinon et al.,
2009), that respond to various signals, including intracellular
bacterial toxins, pathogen-associated molecular patterns
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FIGURE 2 | Summary of the inflammation-inducing pathways in Mycoplasma pneumoniae infection. The following four pathways are involved in the
induction of inflammatory responses: (1) recognition of lipoprotein by TLR2, (2) autophagy-mediated signaling, (3) activation of inflammasomes, and (4)
cytadherence property.
(PAMPs) (Martinon et al., 2004; Miao et al., 2007), damage-
associated molecular patterns (DAMPs) (Kanneganti et al.,
2006; Mariathasan et al., 2006; Sutterwala et al., 2006), and
reactive oxygen species (Dostert et al., 2008; Allen et al.,
2009). Activated inflammasomes cleave the precursors of
pro-inflammatory cytokines, such as IL-1β and IL-18 through
caspase-1 or caspase-11, and release them (Boyden and Dietrich,
2006).
Shimizu et al. (2011) reported that M. pneumoniae induces
eﬄux of ATP from host cells. The eﬄux of ATP activated
inflammasomes via the P2X7 receptor, which is followed by the
secretion of IL-1β. A recent report by Sugiyama et al. (2015)
also demonstrated that M. pnumoniae induces IL-1β through the
NLRP3 inflammasome in a dendritic cell line.
Interestingly, Bose et al. (2014) showed that CARDS toxin
(MPN372) regulates NLRP3 inflammasome activity. CARDs
toxin is a vacuolating cytotoxin produced by some Mycoplasma
species, including M. pneumoniae. Its C-terminal region is
responsible for its vacuolating activity (Kannan and Baseman,
2006; Kannan et al., 2014). Its N-terminal region shares
sequence similarity with pertussis toxin and is essential for
its ADP-ribosylating activity. In this study, they demonstrated
that CARDS toxin activates inflammasomes through the
ADP-ribosylation of NLRP3 and enhances the secretion of IL-1β.
Taken together, these findings suggest that inflammasomes
play an important role in the inflammation induced by
M. pneumoniae.
Cytadherence of M. pneumoniae and
Inflammation
Cytadherence property is one of the unique characteristics
of M. pneumoniae. Cytadherence in the respiratory tract, the
initial event in M. pneumoniae infection, is mediated by
P1 (MPN141) adhesin and other accessory proteins, such as
P30 and HMW proteins (Krause and Balish, 2001; Balish
and Krause, 2002; Miyata, 2008a,b). The relationship between
cytoadherence and the induction of inflammatory responses
was first reported in Yang et al. (2002). They demonstrated
that protease treatment or anti-P1 antibody treatment decreases
the induction of pro-inflammatory cytokines, including IL-1β.
Hoek et al. (2005) reported that culturing M. pneumoniae in
polypropylene bottles reduces the expression of P1 adhesin.
Under these conditions, the induction of IL-4 from mast
cells was significantly decreased. As described above, Shimizu
et al. reported that M. pneumoniae induces the eﬄux of ATP
from host cells, followed by the activation of inflammasomes
and secretion of IL-1β. In this study, they also reported
that cytadherence-deficient mutants lacking P90 and P40
(MPN142, 130 kDa precursor) or HMW1 and P30 (MPN447
and MPN453, respectively) fail to induce IL-1β through ATP
eﬄux. Cytadherence was also associated with autophagy/TLR4-
mediated induction of inflammatory responses. Mutation in
ABC-transporter (MPN333), and F0F1 ATP synthase subunit ε
(MPN597) failed to induce inflammatory responses, and these
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mutants showed a deficiency in cytadherence (Shimizu et al.,
2014). Taken together, these findings indicate that cytadherence
of M. pneumoniae is strongly associated with the induction of
inflammatory responses.
CONCLUSION
In this review, the molecular mechanisms of inflammatory
responses induced by M. pneumoniae were reviewed (Figure 2).
The following four pathways are important for the induction
of inflammatory responses in M. pneumoniae infection: 1)
recognition of lipoprotein by TLR2, 2) autophagy-mediated
signaling; 3) activation of inflammasomes, and 4) cytadherence
property. Lipoproteins, which were the first immunostimulants
discovered in Mycoplasma species, have been well studied.
However, the structures of the lipoproteins in Mycoplasma
species are identical to those of lipoproteins from other
bacteria, including normal microflora. Therefore, lipoproteins
alone are insufficient to explain the inflammatory responses
induced by M. pneumoniae. M. pneumoniae also has the
ability to induce inflammatory responses through a TLR2-
independent pathway. Autophagy and TLR4 are involved
in this induction. Some pro-inflammatory cytokines, such
as IL-1β and IL-18, are matured and released through
inflammasome activation. Inflammasome activation is necessary
to release these cytokines during M. pneumoniae infection.
It is noteworthy that CARDS toxin enhances inflammasome
activation. The distribution of CARDS toxin in Mycoplasma
species is limited to a small number of Mycoplasma species.
In addition, cytadherent property of M. pneumoniae is strongly
associated with the autophagy/TLR4- and inflammasome-
mediated induction of inflammatory responses. Although
some Mycoplasma species, such as M. genitalium and M.
gallisepticum, have partially similar adhesin, cytadherence
mediated by P1 adhesin is unique in M. pneumoniae. These
characteristics may contribute to the greater ability of M.
pneumoniae to induce inflammatory responses than non-
pathogenic Mycoplasma species.
In addition to inflammation-inducing factors, M. pneumoniae
shows cytotoxicity through CARDS toxin, nuclease, and
hydrogen peroxide produced during glycerol metabolism.
The symptoms of mycoplasmal pneumonia, such as fever
and severe cough, are thought to appear as a result of
a combination of inflammation and cytotoxicity induced
by M. pneumoniae. Mycoplasmal pneumonia is still an
important issue in the field of pediatric medicine. Although
measures to prevent mycoplasmal pneumonia are desired
worldwide, preventive measures, including vaccines, have not
been developed. Therefore, the inflammation-inducing factors of
M. pneumoniae described here may be suitable targets for the
development of new preventive measures.
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